Genetic Technologies
GENE
#10485
Rank
โ‚ฌ3.18 M
Marketcap
0,66ย โ‚ฌ
Share price
0.00%
Change (1 day)
-71.59%
Change (1 year)

Revenue for Genetic Technologies (GENE)

Revenue in 2008 (TTM): โ‚ฌ11.3 Million

According to Genetic Technologies's latest financial reports the company's current revenue (TTM ) is โ‚ฌ14.67 Million. In 2007 the company made a revenue of โ‚ฌ11.39 Million an increase over the revenue in the year 2006 that were of โ‚ฌ5.31 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Genetic Technologies from 2005 to 2008

Annual revenue

Year Revenue Change
2008 (TTM) โ‚ฌ11.3 M-0.73%
2007 โ‚ฌ11.39 M114.43%
2006 โ‚ฌ5.31 M-9.83%
2005 โ‚ฌ5.89 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eterna Therapeutics
ERNA
โ‚ฌ0 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
โ‚ฌ0.70 B 4,725.51%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ11.80 B 80,385.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ9.30 B 63,339.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚ฌ5.92 M-59.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Danaher
DHR
โ‚ฌ20.81 B 141,794.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ37.51 B 255,617.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
โ‚ฌ0.76 B 5,085.60%๐Ÿ‡บ๐Ÿ‡ธ USA